Take­da part­ner Finch joins forces with Cresto­vo, leap­ing in­to a mid-stage mi­cro­bio­me study

About 6 months af­ter Take­da part­nered up with mi­cro­bio­me biotech Finch Ther­a­peu­tics on a pre­clin­i­cal pro­gram for IBD, the Somerville, MA-based com­pa­ny has struck a …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.